SCOPUS 정보 검색 플랫폼

Journal of Neurology

Volumn 255, Issue SUPPL. 6, 2008, Pages 28-35

Monoclonal antibodies in the therapy of multiple sclerosis : AAAn overview

(5) Rommer, P S a Stuve O b Goertsches, R a Mix, E a Zettl, U K a

a UNIVERSITY OF ROSTOCK (Germany)

b UNIVERSITY OF TEXAS AT DALLAS (United States)

Author keywords

Alemtuzumab; Daclizumab; Multiple sclerosis; Natalizumab; Rituximab

Indexed keywords

ALEMTUZUMAB; BETA1A INTERFERON; CD20 ANTIGEN; DACLIZUMAB; INTERLEUKIN 2 RECEPTOR ALPHA; MONOCLONAL ANTIBODY; NATALIZUMAB; RITUXIMAB; IMMUNOLOGIC FACTOR;

ACUTE KIDNEY FAILURE; ADD ON THERAPY; ARTHRALGIA; ASTHENIA; AUTOIMMUNE HEMOLYTIC ANEMIA; BRAIN VASCULITIS; CLINICAL TRIAL; CROHN DISEASE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FATIGUE; FEVER; GRAVES DISEASE; HEADACHE; HEMOPHILIA; HUMAN; HYPERTENSION; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; LIVER TOXICITY; LYMPHADENOPATHY; MELANOMA; MULTIPLE SCLEROSIS; NAUSEA; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RASH; REVIEW; RHEUMATOID ARTHRITIS; RIGOR; SKIN INFLAMMATION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOTIC THROMBOCYTOPENIC PURPURA; VOMITING; ANIMAL; CHEMISTRY; CLASSIFICATION; IMMUNOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; CLINICAL TRIALS AS TOPIC; HUMANS; IMMUNOLOGIC FACTORS; MULTIPLE SCLEROSIS;

EID: 64149096860 PISSN: 03405354 EISSN: 14321459 Source Type: Journal
DOI: 10.1007/s00415-008-6006-x Document Type: Review

Times cited : (21)

References (86)

1
- 33751383448
- Aksamit 2006 Neurologist 12 293
- (2006) Neurologist , vol.12 , pp. 293
- Aksamit¹

2
- 41849116363
- Bar-Or 2008 Ann Neurol 63 395
- (2008) Ann Neurol , vol.63 , pp. 395
- Bar-Or¹

3
- 36048935308
- Berger 2007 Curr Neurol Neurosci Rep 7 461
- (2007) Curr Neurol Neurosci Rep , vol.7 , pp. 461
- Berger¹

4
- 33645812129
- Bielekova 2006 Proc Natl Acad Sci USA 103 5941
- (2006) Proc Natl Acad Sci USA , vol.103 , pp. 5941
- Bielekova¹

5
- 2942537826
- Bielekova 2004 Proc Natl Acad Sci USA 101 8705
- (2004) Proc Natl Acad Sci USA , vol.101 , pp. 8705
- Bielekova¹

6
- 38049000341
- Boren 2008 J Autoimmun 30 90
- (2008) J Autoimmun , vol.30 , pp. 90
- Boren¹

7
- 41649115484
- Buttmann 2008 Expert Rev Neurother 8 433
- (2008) Expert Rev Neurother , vol.8 , pp. 433
- Buttmann¹

8
- 34547488545
- Calabrese 2007 Arthritis Rheum 56 2116
- (2007) Arthritis Rheum , vol.56 , pp. 2116
- Calabrese¹

9
- 34848816850
- Calabresi 2007 Neurology 69 1391
- (2007) Neurology , vol.69 , pp. 1391
- Calabresi¹

10
- 0023747187
- Champlin 1988 Neurology 38 47
- (1988) Neurology , vol.38 , pp. 47
- Champlin¹

11
- 0025068211
- Cobbold 1990 Prog Clin Biol Res 333 139
- (1990) Prog Clin Biol Res , vol.333 , pp. 139
- Cobbold¹

12
- 2642552117
- Confavreux 2004 Clin Neurol Neurosurg 106 263
- (2004) Clin Neurol Neurosurg , vol.106 , pp. 263
- Confavreux¹

13
- 2642557746
- Coles 2004 Clin Neurol Neurosurg 106 270
- (2004) Clin Neurol Neurosurg , vol.106 , pp. 270
- Coles¹

14
- 54949143968
- Alemtuzumab vs. interferon beta-1a in early multiple sclerosis
- CAMMS223 Trial Investigators, Coles AJ, Compston DA, Selmaj KW, Lake SL, Moran S, Margolin DH, Norris K, Tandon PK (2008) Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. N Engl J Med. 359(17):1786-801
- (2008) N Engl J Med. , vol.359 , Issue.17 , pp. 1786-801
- Coles, A.J.¹ Compston, D.A.² Selmaj, K.W.³ Lake, S.L.⁴ Moran, S.⁵ Margolin, D.H.⁶ Norris, K.⁷ Tandon, P.K.⁸

15
- 31544467633
- Coles 2006 J Neurol 253 98
- (2006) J Neurol , vol.253 , pp. 98
- Coles¹

16
- 0032882173
- Coles 1999 Ann Neurol 46 296
- (1999) Ann Neurol , vol.46 , pp. 296
- Coles¹

17
- 0033552391
- Coles 1999 Lancet 354 1691
- (1999) Lancet , vol.354 , pp. 1691
- Coles¹

18
- 33746565387
- Cree 2006 Neurologist 12 171
- (2006) Neurologist , vol.12 , pp. 171
- Cree¹

19
- 16844366404
- Cree 2005 Neurology 64 1270
- (2005) Neurology , vol.64 , pp. 1270
- Cree¹

20
- 33751085414
- Cross 2006 J Neuroimmunol 180 63
- (2006) J Neuroimmunol , vol.180 , pp. 63
- Cross¹

21
- 0026518375
- Crowe 1992 Clin Exp Immunol 87 105
- (1992) Clin Exp Immunol , vol.87 , pp. 105
- Crowe¹

22
- 65449161393
- EMEA pressoffice
- London 20 March
- EMEA pressoffice. Hepatotoxicity London 20 March 2008, www.emea.europa.eu/pressoffice/chmp.htm
- (2008) Hepatotoxicity

23
- 37149030961
- Engelhardt 2008 Neurodegener Dis 5 16
- (2008) Neurodegener Dis , vol.5 , pp. 16
- Engelhardt¹

24
- 33947246465
- Fanale 2007 Drugs 67 333
- (2007) Drugs , vol.67 , pp. 333
- Fanale¹

25
- 0034501632
- Flynn 2000 Curr Opin Oncol 12 574
- (2000) Curr Opin Oncol , vol.12 , pp. 574
- Flynn¹

26
- 65449166823
- Freim Wahl 2007 Clin Neuropathol 26 68
- (2007) Clin Neuropathol , vol.26 , pp. 68
- Wahl, F.¹

27
- 40949154401
- Garvey 2008 Br J Haematol 141 149
- (2008) Br J Haematol , vol.141 , pp. 149
- Garvey¹

28
- 34347226702
- Gold 2007 J Neuroimmunol 187 156
- (2007) J Neuroimmunol , vol.187 , pp. 156
- Gold¹

29
- 33845456586
- Greenlee 2006 Int MS J 13 100
- (2006) Int MS J , vol.13 , pp. 100
- Greenlee¹

30
- 0034468346
- Grillo-López 2000 Semin Oncol 27 9
- (2000) Semin Oncol , vol.27 , pp. 9
- Grillo-López¹

31
- 0024204319
- Hale 1988 Lancet 17 1394
- (1988) Lancet , vol.17 , pp. 1394
- Hale¹

32
- 39049142995
- Hauser 2008 N Engl J Med 358 676
- (2008) N Engl J Med , vol.358 , pp. 676
- Hauser¹

33
- 41649114547
- B-cell-targeted treatment for multiple sclerosis: Mechanism of action and clinical data
- Hawker K (2008) B-cell-targeted treatment for multiple sclerosis: mechanism of action and clinical data. Curr Opin Neurol (Suppl 1):S19-S25
- (2008) Curr Opin Neurol (Suppl 1)
- Hawker, K.¹

34
- 40149098173
- Hirst 2008 J Neurol 255 231
- (2008) J Neurol , vol.255 , pp. 231
- Hirst¹

35
- 65449188296
- http://clinicaltrial.gov

36
- 65449163850
- http://www.emea.europa.eu/humandocs/PDFs/EPAR/tysabri/H-603-Annex-en.pdf

37
- 65449128118
- http://www.fda.gov/cder/drug/infopage/natalizumab/default.htm

38
- 34548488466
- Hünig 2007 Adv Immunol 95 111
- (2007) Adv Immunol , vol.95 , pp. 111
- Hünig¹

39
- 34447300469
- Johnson 2007 Neurologist 13 182
- (2007) Neurologist , vol.13 , pp. 182
- Johnson¹

40
- 37149040149
- Jones 2008 Neurodegener Dis 5 27
- (2008) Neurodegener Dis , vol.5 , pp. 27
- Jones¹

41
- 34047272106
- Kappos 2007 Lancet Neurol 6 431
- (2007) Lancet Neurol , vol.6 , pp. 431
- Kappos¹

42
- 22844439662
- Kleinschmidt-DeMasters 2005 N Engl J Med 353 369
- (2005) N Engl J Med , vol.353 , pp. 369
- Kleinschmidt-Demasters¹

43
- 0037182164
- Koch 2002 Transplantation 73 1640
- (2002) Transplantation , vol.73 , pp. 1640
- Koch¹

44
- 0038318967
- Kovarik 2003 Expert Opin Emerg Drugs 8 47
- (2003) Expert Opin Emerg Drugs , vol.8 , pp. 47
- Kovarik¹

45
- 20444396908
- Kümpfel 2005 MMW Fortschrit Med 147 83
- (2005) MMW Fortschrit Med , vol.147 , pp. 83
- Kümpfel¹

46
- 22844445230
- Langer-Gould 2005 N Engl J Med 353 375
- (2005) N Engl J Med , vol.353 , pp. 375
- Langer-Gould¹

47
- 84993741950
- Linker 2008 Ther Adv Neurol Dis 1 33
- (2008) Ther Adv Neurol Dis , vol.1 , pp. 33
- Linker¹

48
- 43249103954
- Lutterotti 2008 Lancet Neurol 7 538
- (2008) Lancet Neurol , vol.7 , pp. 538
- Lutterotti¹

49
- 1842368507
- Maloney 1997 Blood 90 2188
- (1997) Blood , vol.90 , pp. 2188
- Maloney¹

50
- 37149023520
- Martin 2008 Neurodegener Dis 5 23
- (2008) Neurodegener Dis , vol.5 , pp. 23
- Martin¹

51
- 48949092246
- Mechetner 2007 Methods Mol Biol 378 1
- (2007) Methods Mol Biol , vol.378 , pp. 1
- Mechetner¹

52
- 0037413467
- Miller 2003 N Engl J Med 348 15
- (2003) N Engl J Med , vol.348 , pp. 15
- Miller¹

53
- 13444274684
- Monson 2005 Arch Neurol 62 258
- (2005) Arch Neurol , vol.62 , pp. 258
- Monson¹

54
- 38349180686
- Montalban 2007 Mult Scler 13 A18
- (2007) Mult Scler , vol.13 , pp. 18
- Montalban¹

55
- 0029869119
- Moreau 1996 Brain 119 225
- (1996) Brain , vol.119 , pp. 225
- Moreau¹

56
- 0030177999
- Moreau 1996 Mult Scler 1 357
- (1996) Mult Scler , vol.1 , pp. 357
- Moreau¹

57
- 85101730234
- Moreau 1994 Lancet 344 486
- (1994) Lancet , vol.344 , pp. 486
- Moreau¹

58
- 85046912654
- Mullen 2008 N Engl J Med 358 647
- (2008) N Engl J Med , vol.358 , pp. 647
- Mullen¹

59
- 33845608619
- Escalating immunomodulatory therapy of multiple sclerosis
- Multiple Sklerose Therapie Konsensus Gruppe (MSTKG)
- Multiple Sklerose Therapie Konsensus Gruppe (MSTKG) (2006) Escalating immunomodulatory therapy of multiple sclerosis. Nervenarzt 77:1506-1518
- (2006) Nervenarzt , vol.77 , pp. 1506-1518

60
- 2942589194
- O'Connor 2004 Neurology 62 2038
- (2004) Neurology , vol.62 , pp. 2038
- O'Connor¹

61
- 0033546980
- Paolillo 1999 Neurology 53 751
- (1999) Neurology , vol.53 , pp. 751
- Paolillo¹

62
- 41549115177
- Pelosini 2008 Ann Hematol 87 405
- (2008) Ann Hematol , vol.87 , pp. 405
- Pelosini¹

63
- 33644584352
- Polman 2006 N Engl J Med 354 899
- (2006) N Engl J Med , vol.354 , pp. 899
- Polman¹

64
- 0033964862
- Przepiorka 2000 Blood 95 83
- (2000) Blood , vol.95 , pp. 83
- Przepiorka¹

65
- 17644398787
- Rice 2005 Neurology 64 1336
- (2005) Neurology , vol.64 , pp. 1336
- Rice¹

66
- 34548142973
- Rose 2007 Neurology 69 785
- (2007) Neurology , vol.69 , pp. 785
- Rose¹

67
- 9644265478
- Rose 2004 Ann Neurol 56 864
- (2004) Ann Neurol , vol.56 , pp. 864
- Rose¹

68
- 3042739652
- Rudick 2004 Expert Rev Neurother 4 571
- (2004) Expert Rev Neurother , vol.4 , pp. 571
- Rudick¹

69
- 33644608613
- Rudick 2006 N Engl J Med 354 911
- (2006) N Engl J Med , vol.354 , pp. 911
- Rudick¹

70
- 44949109211
- Sathasivam 2008 Nat Clin Pract Neurol 4 317
- (2008) Nat Clin Pract Neurol , vol.4 , pp. 317
- Sathasivam¹

71
- 36849071827
- Schuna 2007 Pharmacotherapy 27 1702
- (2007) Pharmacotherapy , vol.27 , pp. 1702
- Schuna¹

72
- 65449118426
- Sorensen 2005 Lancet Neurol 4 9
- (2005) Lancet Neurol , vol.4 , pp. 9
- Sorensen¹

73
- 0016742233
- Sponzilli 1975 Neurology 25 664
- (1975) Neurology , vol.25 , pp. 664
- Sponzilli¹

74
- 53049107590
- Stüve 2008 J Neurol Sci 274 39
- (2008) J Neurol Sci , vol.274 , pp. 39
- Stüve¹

75
- 33846969181
- Stüve 2007 Arch Neurol 64 169
- (2007) Arch Neurol , vol.64 , pp. 169
- Stüve¹

76
- 33646347610
- Stüve 2006 Ann Neurol 59 743
- (2006) Ann Neurol , vol.59 , pp. 743
- Stüve¹

77
- 43249101050
- ITP following treatment of multiple sclerosis patients with alemtuzumab in CAMMS223: Case reports and risk management plan implementation
- The CAMMS223 Study Group
- Sullivan H, The CAMMS223 Study Group, ITP Following Treatment of Multiple Sclerosis Patients with Alemtuzumab in CAMMS223: Case Reports and Risk Management Plan Implementation. Neurology (Suppl 1):A206
- Neurology (Suppl 1)
- Sullivan, H.¹

78
- 0033546663
- Tubridy 1999 Neurology 53 466
- (1999) Neurology , vol.53 , pp. 466
- Tubridy¹

79
- 65449137955
- Tysabri (natalizumab) Information center 31 July
- Tysabri (natalizumab) Information center. Form 8-K regarding other events; 31 July 2008. www.biogenidec.com
- (2008) Form 8-K Regarding Other Events

80
- 22844445587
- Van Assche 2005 N Engl J Med 353 362
- (2005) N Engl J Med , vol.353 , pp. 362
- Van Assche¹

81
- 34347325946
- Vermersch 2007 Rev Neurol 163 682
- (2007) Rev Neurol , vol.163 , pp. 682
- Vermersch¹

82
- 6844236357
- Vincenti 1998 N Engl J Med 338 161
- (1998) N Engl J Med , vol.338 , pp. 161
- Vincenti¹

83
- 33846868833
- Waldmann 2007 J Clin Immunol 27 1
- (2007) J Clin Immunol , vol.27 , pp. 1
- Waldmann¹

84
- 21244471959
- Wingerchuk 2005 Curr Treat Options Neurol 7 173
- (2005) Curr Treat Options Neurol , vol.7 , pp. 173
- Wingerchuk¹

85
- 65449133969
- Yao 2008 Plos One 3 e208
- (2008) Plos One , vol.3 , pp. 208
- Yao¹

86
- 33644605483
- Yousry 2006 N Engl J Med 354 924
- (2006) N Engl J Med , vol.354 , pp. 924
- Yousry¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.